Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bronchiectasis Market Overview

The Bronchiectasis market size was valued at $408.2 million across the 3MM in 2021. The market is expected to grow at a CAGR of more than 8% during the forecast period. AMD is one of the leading causes of irreversible vision loss. Bronchiectasis is defined by the damage to the bronchi, causing abnormal dilation and scarring. The airways become inflamed with thick mucus that is difficult to clear, whose build up creates an environment for bacterial growth. This uncontrolled bacterial growth leads to frequent infections. The cycle of repeated infections can, in turn, cause further damage to the airways. Bronchiectasis can occur throughout the lung or in a single section of the lung.

The Bronchiectasis market research report provides an overview of the risk factors, comorbidities, and global and historical trends for Bronchiectasis in the three major markets (3MM: US, Germany, and UK). It also includes a 10-year analytical forecast for total global sales of Bronchiectasis. The total and forecasted prevalent drug sales of Bronchiectasis are further segmented by age, sex, and stage in these markets.

Bronchiectasis Market Overview

Bronchiectasis Market Overview

To gain more information on the Bronchiectasis market forecast, download a free report sample

Key Bronchiectasis Market Drivers

The major driver for the Bronchiectasis market growth will be the anticipated high cost of therapy for new first in-class procedures. Continued usage of symptomatic drug classes such as antibiotics, mucolytics, and bronchodilators, and the lack of available disease modifying treatments will be the strongest driver of the market in the 3MM.

Key Sex Segments in the Bronchiectasis Market

The Bronchiectasis market can be segmented based on sex into men and women.

In the 3MM combined, the number of diagnosed prevalent cases of Bronchiectasis was higher in women than in men in 2021. However, the US had the highest number of diagnosed prevalent cases of Bronchiectasis. Germany had the smallest variation in the number of diagnosed prevalent cases between men and women.

Bronchiectasis Market Analysis by Sex

Bronchiectasis Market Analysis by Sex

For more sex segment insights, download a free report sample

3MM Country-Wise Outlook of the Diagnosed Prevalent Cases in the Bronchiectasis Market

The US is anticipated to experience the fastest growth during the forecast period followed by UK, and Germany.

Bronchiectasis Market Analysis by Countries

Bronchiectasis Market Analysis by Countries

For more insights on the country-wise outlook, download a free report sample

Unmet Needs in Bronchiectasis

  • Lack of approved therapies: There are some pipeline agents such as Fasenra and brensocatib in late-stage development however, there has historically been a high trial failure rate in bronchiectasis.
  • Improved Diagnostic Methods: Bronchiectasis is a very heterogenous condition and the only way to accurately diagnose it is through a CT scan, which is expensive and can place a burden on healthcare budgets and systems.
  • Increased Awareness and Education: A lack of knowledge among patients and physicians keeps the diagnosis challenging, resulting in many undiagnosed cases and patients who do not seek treatment.

Key Players in the Bronchiectasis Market

Some of the key players in the Bronchiectasis market are AstraZeneca, Insmed, KamadaPharma, Zambon Pharma, and Novartis.

Bronchiectasis Market Report Scope

  Market size (Year – 2021)  $408.2 million
  Growth rate (CAGR)  >8%
  Forecast period 2021-2031
Key Sex Segments Men and Women
Key Countries US, UK, and Germany
  Key Players AstraZeneca, Insmed, KamadaPharma, Zambon Pharma, and Novartis

Scope 

  • Overview of Age-Related Macular Degeneration – including epidemiology, disease etiology, and management.
  • Topline Bronchiectasis drugs market revenue, the annual cost of therapy, and anticipated sales for major late-stage pipeline drugs.
  • Key topics covered include assessment of current and pipeline therapies, unmet needs, current and future players, and market outlook for the US, UK, and Germany over the 10-year forecast period.
  • Pipeline analysis: Emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
  • Analysis of the current and future market competition in the global Bronchiectasis therapeutics market. Insightful review of the key industry drivers, restraints, and challenges

Reasons to Buy

The report will enable you to:

  • Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
  • Develop business strategies by understanding the trends shaping and driving the global Bronchiectasis therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Bronchiectasis market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Track drug sales in the global Bronchiectasis therapeutics market from 2021 to 2031.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

AstraZeneca
Insmed
Kamada Pharmaceuticals
Novartis
Zambon Pharma

Table of Contents

Table of Contents (PowerPoint Deck)

1 Executive Summary

1.1 Executive Summary

2 Disease Overview

2.1 Overview of Bronchiectasis

2.2 Classification of Bronchiectasis

2.3 Bronchiectasis SWOT Analysis

3 Epidemiology

3.1 Diagnosed Prevalent Cases of Bronchiectasis, Men and Women, 2021–31

3.2 Sources and Methodology

4 Current Treatment Options

4.1 Treatment Paradigm

4.2 Marketed Products

4.3 Product Profile: Antibiotics (Oral, IV, Inhaled)

4.4 Product Profile: Bronchodilators

4.5 Product Profile: Bronchitol

4.6 Product Profile: Hypertonic Saline

5 Unmet Needs and Opportunities

5.1 Unmet Needs in Bronchiectasis

6 Pipeline Assessment

6.1 Bronchiectasis Pipeline Overview

6.2 Leading Pipeline Agents

6.3 Product Profile: AstraZeneca’s Fasenra (benralizumab)

6.4 Product Profile: Insmed’s Brensocatib

6.5 Product Profile: Kamada Pharmaceutical’s AAT inhibitor

6.6 Product Profile: Zambon Pharma’s NCFBE-1 & NCFBE-2

6.7 Product Profile: Novartis’s Icenticaftor

7 R&D Strategies

7.1 Trends in Clinical Trial Design in Bronchiectasis

7.2 Trends in Deal-Making in Bronchiectasis

8 Market Outlook

8.1 Bronchiectasis Market Forecast

8.2 Market Drivers and Barriers

9 Appendix

9.1 Bibliography

9.2 Primary Research: KOL Information

9.3 About the Authors

10 Contact Us

Frequently asked questions

Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 thematic reports
Currency USD
$6,995

Can be used by individual purchaser only

$20,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 in real time.

  • Access a live Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.